Review
Neoadjuvant and Perioperative Immunotherapy for Resectable Esophageal Squamous Cell Carcinoma: Current Evidence, Endpoints, and Clinical Integration
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.